MPS Pharmaa Limited (BOM:531686)
India · Delayed Price · Currency is INR 1.990
0.00 (0.00%)
At close: Aug 17, 2026
MPS Pharmaa Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 0.01 | 0.02 | 0.06 | 0.07 | 0.14 |
Cash & Short-Term Investments | 0.01 | 0.01 | 0.02 | 0.06 | 0.07 | 0.14 |
Cash Growth | -48.00% | -47.79% | -56.85% | -20.50% | -46.90% | 8.73% |
Accounts Receivable | - | - | 0.09 | 0.17 | 0.26 | 0.35 |
Other Receivables | - | - | - | - | - | 0.19 |
Receivables | - | - | 0.09 | 0.17 | 0.26 | 0.54 |
Inventory | - | 3.5 | 5.04 | 5.04 | 5.04 | 5.49 |
Prepaid Expenses | - | 0.04 | 0.04 | 0.05 | 0.07 | 0.04 |
Other Current Assets | - | 15.11 | 15.31 | 15.91 | 15.6 | 14.09 |
Total Current Assets | - | 18.67 | 20.49 | 21.22 | 21.04 | 20.29 |
Property, Plant & Equipment | - | 60.75 | 67.45 | 72.75 | 75.45 | 75.93 |
Long-Term Investments | - | 5.38 | 5.38 | 5.38 | 5.38 | 5.38 |
Other Long-Term Assets | - | - | 0 | - | - | - |
Total Assets | - | 84.8 | 93.32 | 99.35 | 101.86 | 101.6 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 1.87 | 2.01 | 1.99 | 1.99 | 1.22 |
Accrued Expenses | - | - | 2.84 | 1.79 | 1.49 | 1.32 |
Short-Term Debt | - | 75.24 | 74.58 | 72.74 | 67.64 | 58.07 |
Other Current Liabilities | - | 4.78 | 1.25 | 0.9 | 0.56 | 0.2 |
Total Current Liabilities | - | 81.89 | 80.67 | 77.42 | 71.69 | 60.82 |
Pension & Post-Retirement Benefits | - | - | 0.94 | 1.17 | 1.02 | 1.1 |
Long-Term Deferred Tax Liabilities | - | 0.4 | 0.75 | 0.71 | 0.91 | 1.06 |
Other Long-Term Liabilities | - | 1.83 | 0.15 | 0.36 | 0.34 | 0.36 |
Total Liabilities | - | 84.11 | 82.51 | 79.66 | 73.95 | 63.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 191.11 | 191.11 | 191.11 | 191.11 | 191.11 |
Retained Earnings | - | - | -181.35 | -172.37 | -164.06 | -153.55 |
Comprehensive Income & Other | - | -190.43 | 1.04 | 0.94 | 0.86 | 0.7 |
Shareholders' Equity | 0.69 | 0.69 | 10.81 | 19.69 | 27.91 | 38.26 |
Total Liabilities & Equity | - | 84.8 | 93.32 | 99.35 | 101.86 | 101.6 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 75.24 | 75.24 | 74.58 | 72.74 | 67.64 | 58.07 |
Net Cash (Debt) | -75.23 | -75.23 | -74.55 | -72.68 | -67.57 | -57.94 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.83 | -3.91 | -3.90 | -3.80 | -3.54 | -3.03 |
Filing Date Shares Outstanding | 19.83 | 18.91 | 19.11 | 19.11 | 19.11 | 19.11 |
Total Common Shares Outstanding | 19.83 | 18.91 | 19.11 | 19.11 | 19.11 | 19.11 |
Working Capital | - | -63.22 | -60.18 | -56.2 | -50.65 | -40.53 |
Book Value Per Share | 0.04 | 0.04 | 0.57 | 1.03 | 1.46 | 2.00 |
Tangible Book Value | 0.69 | 0.69 | 10.81 | 19.69 | 27.91 | 38.26 |
Tangible Book Value Per Share | 0.04 | 0.04 | 0.57 | 1.03 | 1.46 | 2.00 |
Land | - | - | 4.84 | 4.84 | 4.84 | 4.84 |
Buildings | - | - | 50.5 | 50.5 | 50.5 | 50.43 |
Machinery | - | - | 96.33 | 103.22 | 103.05 | 101.95 |
Construction In Progress | - | - | 29.11 | 32.6 | 34.01 | 34.21 |